Never Run Out Of Buyers To Sell To.

Abata Therapeutics is a clinical-stage biotech company dedicated to transforming lives with Treg therapies for severe autoimmune and inflammatory diseases. Founded by pioneers in Treg biology, TCR and antigen discovery, disease pathogenesis, and molecular and imaging biomarkers, Abata has developed a differentiated product engine to create a pipeline of novel engineered Treg cell therapies that are tissue-specific, robust, and durable. Abata’s lead programs are in progressive multiple sclerosis and type 1 diabetes – tissue-specific autoimmune diseases with substantial unmet need, supporting a…
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.